Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Dan Henrohn"'
Autor:
Jacob P. Thyssen, Dan Henrohn, Maureen P. Neary, Kirk Geale, Alexander R. Dun, Gustaf Ortsäter, Ingrid Lindberg, Anna De Geer, Petra Neregård, Amy Cha, Joseph C. Cappelleri, William Romero, Laura vonKobyletzki
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 1, Pp 128-141 (2024)
Abstract Background Atopic dermatitis (AD) is a chronic inflammatory skin disease that has been shown to be associated with allergic comorbidities. However, studies examining comorbidities in patients with AD are incomplete, which may contribute to s
Externí odkaz:
https://doaj.org/article/682733713428468e82be9f706d9b21ba
Autor:
Kevin L. Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal, Maria Galindo, John C. Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B. Shapiro, Thomas V. Jones, Annette Diehl, Chinyu Su, Julian Panés, Stanley B. Cohen
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 2, Pp 357-373 (2022)
Abstract Introduction This post hoc analysis evaluated influenza adverse events (AEs) across rheumatoid arthritis (RA), ulcerative colitis (UC), and psoriatic arthritis (PsA) tofacitinib clinical programs. Methods Available data from phase 1, randomi
Externí odkaz:
https://doaj.org/article/636def3d7be64a6abbfb716f2f5fce89
Autor:
Gustaf Ortsäter, Anna De Geer, Alexander Rieem Dun, Kirk Geale, Ingrid Lindberg, Jacob Pontoppidan Thyssen, Laura B. vonKobyletzki, Alexandra Metsini, Dan Henrohn, Petra Neregård, Amy Cha, Joseph C. Cappelleri, William Romero, Maureen P. Neary
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 4, Pp 326-343 (2022)
Abstract Background Atopic dermatitis (AD) is a common inflammatory skin disease while the economic burden of AD by severity is not adequately understood. Objective To estimate the societal economic burden and to identify cost determinants of AD. Met
Externí odkaz:
https://doaj.org/article/885f76a34f1541309327f1bf780ec2de
Autor:
Kristofer Andréasson, Karl Neringer, Dirk M. Wuttge, Dan Henrohn, Jan Marsal, Roger Hesselstrand
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-9 (2020)
Abstract Objective Mycophenolate mofetil (MMF) is an established therapy for systemic sclerosis (SSc), but its pharmacokinetics in this disease remains unexplored. We have investigated drug exposure in MMF-treated patients with SSc in relation to cli
Externí odkaz:
https://doaj.org/article/a5d1abdd5cb04aa587acdf2b37e798e5
Autor:
Ulrika Gillespie, Anna Alassaad, Margareta Hammarlund-Udenaes, Claes Mörlin, Dan Henrohn, Maria Bertilsson, Håkan Melhus
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e62401 (2013)
Appropriateness of prescribing can be assessed by various measures and screening instruments. The aims of this study were to investigate the effects of pharmacists' interventions on appropriateness of prescribing in elderly patients, and to explore t
Externí odkaz:
https://doaj.org/article/05cc306ee73545ab95e378aa508f6ede
Autor:
Kevin L. Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal, Maria Galindo, John C. Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B. Shapiro, Thomas V. Jones, Annette Diehl, Chinyu Su, Julian Panés, Stanley B. Cohen
Publikováno v:
Scientia
This post hoc analysis evaluated influenza adverse events (AEs) across rheumatoid arthritis (RA), ulcerative colitis (UC), and psoriatic arthritis (PsA) tofacitinib clinical programs.Available data from phase 1, randomized phase 2/3/3b/4 clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89bdb9b44ccbbf9afb8ee0ad5bd81dda
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502143
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502143
Background Pulmonary arterial hypertension (PAH; World Heath Organization [WHO] Group 1) is associated with increased pulmonary arterial pressure and resistance, with pulmonary vascular remodelling. The vascular anatomy of the systemic arteries has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f5c27bd9cea14fbbb54231caf815c2
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-504953
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-504953
Autor:
Gustaf Ortsäter, Anna De Geer, Kirk Geale, Alexander Rieem Dun, Ingrid Lindberg, Jacob P. Thyssen, Laura von Kobyletzki, Natalia Ballardini, Dan Henrohn, Petra Neregård, Amy Cha, Joseph C. Cappelleri, Maureen P. Neary
Publikováno v:
Ortsäter, G, De Geer, A, Geale, K, Rieem Dun, A, Lindberg, I, Thyssen, J P, von Kobyletzki, L, Ballardini, N, Henrohn, D, Neregård, P, Cha, A, Cappelleri, J C & Neary, M P 2022, ' Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases ', Dermatology and Therapy, vol. 12, no. 2, pp. 545-559 . https://doi.org/10.1007/s13555-021-00670-1
Introduction: The use of real-world data offers a possibility to perform large-scale epidemiological studies in actual clinical settings. Despite their many advantages, administrative databases were not designed to be used in research, and the valida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05279ee0ec777835d936659a677b733
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485444
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485444
Effects of inorganic nitrate in a rat model of monocrotaline‐induced pulmonary arterial hypertension
Autor:
Margareta Marusakova, Bianka Zsigmondova, Peter Krenek, Mattias Carlström, Dan Henrohn, Zuzana Kmecova, Jan Klimas, E. Malikova
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 126:99-109
The nitrate-nitrite-nitric oxide (NO) pathway represents an alternative source of NO generation, which is independent of NO synthase and potentiated by hypoxia. Augmentation of this pathway by dietary nitrate has proven favourable effects in several
Autor:
Dan Henrohn, Dirk M. Wuttge, Karl Neringer, Jan Marsal, Kristofer Andréasson, Roger Hesselstrand
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-9 (2020)
Arthritis Research & Therapy
Arthritis Research & Therapy
Objective Mycophenolate mofetil (MMF) is an established therapy for systemic sclerosis (SSc), but its pharmacokinetics in this disease remains unexplored. We have investigated drug exposure in MMF-treated patients with SSc in relation to clinical fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27269b866de4a80960becd2f33a365a1
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-424038
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-424038